Evelo Biosciences Overview
Contact top employees from
Evelo Biosciences
Summary
Evelo Biosciences is a public company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Simba Gill. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Evelo Biosciences varies between 100K and 5.0M. Total funding of the company - $211.5M. To connect with Evelo Biosciences employee register on SignalHire.
Evelo Biosciences industries
Biotechnology
Headquarters Location
Evelo Biosciences Employees Size
100-200 employees
SIC Code
2836
DMA Code
Greater Boston
Founded
2015
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Contact Evelo Biosciences
Organization Website
Social Links
Contact Email
info@evelobio.com
Phone Number
617-577-0300
Evelo Biosciences Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1996 | Public Company | 100 - 250 | 144.1M | $45M | |
| 2010 | Privately Held | 100 - 250 | 19.6M | $229M | |
| 2007 | Privately Held | 25 - 100 | < 1M | $162.3M | |
| 2004 | Public Company | 25 - 100 | 123.3M | $98M | |
| 2011 | Privately Held | 25 - 100 | 9.8M | $7.3M | |
| 2010 | Privately Held | 25 - 100 | 4M | $5.4M | |
| 2014 | Public Company | 1 - 25 | < 1M | $155.5M | |
| 1901 | Public Company | 10K - 50K | 16.4B | $11.4B | |
| 2011 | Public Company | 100 - 250 | 156.7M | $808.7M | |
| 2017 | Privately Held | 25 - 100 | 1.4M | $100M | |
| 2010 | Privately Held | 25 - 100 | 4.4M | $93.3M | |
| 2012 | Public Company | 25 - 100 | 5.2M | $409.9M | |
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2004 | Public Company | 100 - 250 | 6.5M | $610M | |
| 2005 | Public Company | 25 - 100 | 25.2M | $76M | |
| 2017 | Privately Held | 10-50 | < 1M | $3M | |
| 1876 | Public Company | 10K - 50K | 26.7B | $0 | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1980 | - | 10000+ | - | $- | |
| 2008 | - | 500-1000 | - | $- | |
| 1981 | - | 10-50 | - | $- | |
| 2013 | - | 500-1000 | - | $- | |
| 2010 | - | - | $- | ||
| - | - | 10-50 | - | $- | |
| - | - | 10-50 | - | $- |
Evelo Biosciences Funding
By Q3 2019, Evelo Biosciences has participated in at least 4 funding rounds and has raised a minimum of 211.5M. Funding decreased noticeable in Q3 2019 — by 36.5M compared to the previous Q1 2018. Evelo Biosciences raised the least in Q4 2015 at 35.0M, while the most successful funding round in Q1 2018 raised 81.5M.
Evelo Biosciences Employees Turnover 2 quarter 2025
Contact top employees from
Evelo Biosciences
Chun Zhang
Chief Technology & Quality Officer
Eric Mehigan
Director of Financial Planning and Analysis
Brianna MacDonald
Senior Accountant
Maria Sizova
Senior Director Microbiology
Leslie Wardwell
Vice President, Head of Corporate Development and Strategic Integration
Carlos Rodriguez
Director, Business Development and Technical Operations Management
Rachel Cyr
Clinical Research Associate
Julie Smith
Human Resources Consultant
David Perry
Director
Brett Blackman
Advisor
Laura Lande
Consultant
Christopher Davitt
Scientist
William DeVaul
Vice President, Intellectual Property
Anupriya Dutta
Computational Scientist
Michael Rabson
Evelo Fellow
Adam Cartwright
Scientist
David Emerson
Principal Bioprocess Engineer
William Bourque
FP&A Intern
Jessica Tsang
Associate Scientist
Anthony Mannion
Senior Scientist
Benjamin Schattman
Inflammation Co-op
Ricardo Martinez
Lab Support and Facilities Specialist
James Grimaldi
Process Development Engineer Associate
Olivia Kensington
Shareholder
